TARGETING THE APOLIPOPROTEIN E/AMYLOID β INTERACTION BY CPO_A β 17-21P, A NON-TOXIC AND NON-FIBRILLOGENIC PEPTOID, AMELIORATED A β -RELATED PATHOLOGY AND IMPROVED COGNITIVE DECLINE IN A MOUSE MODEL OF ALZHEIMER’S DISEASE